do glp 1 drugs reduce inflammation GLP-1 Drugs: For Multiple Chronic Conditions Stories like this are why
Description
Effect of subcutaneous semaglutide vs
Low incidence of anti-drug antibody in type 2 diabetes patients treated with once-weekly dulaglutide
Initial therapy with the combination of JANUVIA and metformin provided significant improvements in A1C, FPG, and 2-hour PPG compared to placebo, to metformin alone, and to JANUVIA alone (Table 8, Figure 1)
Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure
